News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Bayley Matthew D
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/05/2020 |
4
| Bayley Matthew D (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Disposed/sold 40,000 options to buy
@ $1.25, valued at
$50k
Disposed/sold 50,000 options to buy
@ $1.55, valued at
$77.5k
|
|
| 07/18/2018 |
4/A
| Bayley Matthew D (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.55, valued at
$77.5k
|
|
| 06/19/2018 |
4
| Bayley Matthew D (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.55, valued at
$77.5k
|
|
| 12/04/2017 |
4
| Bayley Matthew D (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.25, valued at
$50k
|
|
| 12/04/2017 |
3
| Bayley Matthew D (Director) has filed a Form 3 on Aevi Genomic Medicine, Inc. |
|
|